Syncor expands operations
Leading provider of nuclear pharmacy services Syncor International has acquired a privately held group of distributors of radiology and cardiology products and a provider of cardiovascular imaging services. The group of distributors comprises
Leading provider of nuclear pharmacy services Syncor International has acquired a privately held group of distributors of radiology and cardiology products and a provider of cardiovascular imaging services. The group of distributors comprises Multi-Medica, Medcon, and affiliated companies, which have focused primarily on markets in Belgium, Luxembourg, and France. Multi-Medica and Medcon distribute radiological film manufactured by several leading imaging supply companies, including Kodak and Konica. They recently diversified their business to include the distribution of cardiology products such as stents, dilation balloons, and valves for heart surgery. Syncor has also acquired privately held InteCardia, which provides cardiovascular imaging services. The acquisition will be immediately accretive to earnings, according to the company. Headquartered in Chapel Hill, NC, InteCardia has approximately 80 employees and last year generated $11 million.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
